title: Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
authors.forename: Steven
authors.initials: S
authors.lastname: Callens
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Bottieau
authors.forename: Peter
authors.initials: P
authors.lastname: Michielsen
authors.forename: Robert
authors.initials: R
authors.lastname: Colebunders
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D015658:HIV Infections / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a